• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[甲状腺髓样癌的图像分析DNA细胞计量术。与组织形态学参数的比较及预后影响]

[Image analysis DNA cytometry in medullary thyroid gland cancer. Comparison with histomorphologic parameters and prognostic effect].

作者信息

Böttger T, Potratz D, Gabbert H, Schernus B, Stöckle M, Klupp J, Junginger T

机构信息

Klinik und Poliklinik für Allgemein- und Abdominalchirurgie, Johannes-Gutenberg-Universität Mainz.

出版信息

Chirurg. 1993 Feb;64(2):122-9.

PMID:8096455
Abstract

In 24 patients with a medullary thyroid cancer a histopathological reexamination was performed. In 16 patients the DNA content was measured. Patients with a diploid or hypotriploid tumor had a 5-year survival rate of 100% in contrast to 48% of patients with a triploid or hypertriploid aneuploid tumor. Aneuploid tumors were more often found in patients with a high pre- or postoperative calcitonin level and lymph node metastasis. No correlation was found between the DNA content and the patients age, sex, preoperative CEA value, tumor size, pT4 stage, invasion of vessels calcitonin immunoreactivity, silver or amyloid staining, and distant metastasis.

摘要

对24例甲状腺髓样癌患者进行了组织病理学复查。对其中16例患者测量了DNA含量。二倍体或亚三倍体肿瘤患者的5年生存率为100%,而三倍体或超三倍体非整倍体肿瘤患者的5年生存率为48%。非整倍体肿瘤更常见于术前或术后降钙素水平高且有淋巴结转移的患者。未发现DNA含量与患者年龄、性别、术前癌胚抗原值、肿瘤大小、pT4分期、血管侵犯、降钙素免疫反应性、银染或淀粉样染色以及远处转移之间存在相关性。

相似文献

1
[Image analysis DNA cytometry in medullary thyroid gland cancer. Comparison with histomorphologic parameters and prognostic effect].[甲状腺髓样癌的图像分析DNA细胞计量术。与组织形态学参数的比较及预后影响]
Chirurg. 1993 Feb;64(2):122-9.
2
[Image analysis of DNA cytometry for assessing prognosis after resection of esophageal cancer].[用于评估食管癌切除术后预后的DNA细胞计量术图像分析]
Chirurg. 1991 Jun;62(6):467-72; discussion 472-3.
3
[The value of quantitative DNA analysis in evaluating the prognosis of differentiated thyroid cancer].
Chirurg. 1994 Mar;65(3):190-3.
4
Prognostic significance of nondiploid DNA determined by flow cytometry in sporadic and familial medullary thyroid carcinoma.
Surgery. 1990 Dec;108(6):972-9; discussion 979-80.
5
[Therapy and prognosis of medullary thyroid cancer].[甲状腺髓样癌的治疗与预后]
Med Klin (Munich). 1991 Jan 15;86(1):8-14.
6
Clinicopathologic and flow cytometric DNA study of medullary thyroid carcinoma.甲状腺髓样癌的临床病理及流式细胞术DNA研究
Surgery. 1990 Dec;108(6):981-5.
7
Medullary thyroid carcinoma: prognostic factors.甲状腺髓样癌:预后因素
J Otolaryngol. 1993 Jun;22(3):180-3.
8
Management and outcome of recurrent well-differentiated thyroid carcinoma.复发性高分化甲状腺癌的管理与预后
Arch Otolaryngol Head Neck Surg. 2004 Jul;130(7):819-24. doi: 10.1001/archotol.130.7.819.
9
[Flow cytometric DNA measurements of thyroid carcinomas].
Gan No Rinsho. 1989 Jul;35(8):886-90.
10
Prognostic variables and calcitonin in medullary thyroid cancer.甲状腺髓样癌的预后变量与降钙素
Laryngoscope. 2005 Aug;115(8):1445-50. doi: 10.1097/01.mlg.0000168114.90852.a6.